BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1429341)

  • 1. T-cell activation-associated antigen expression by neoplastic T-cells.
    Chadburn A; Inghirami G; Knowles DM
    Hematol Pathol; 1992; 6(3):131-41. PubMed ID: 1429341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells.
    Chadburn A; Inghirami G; Knowles DM
    Hematol Pathol; 1992; 6(4):193-202. PubMed ID: 1362727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hairy cell leukemia-associated antigen LeuM5 (CD11c) is preferentially expressed by benign activated and neoplastic CD8 T cells.
    Chadburn A; Inghirami G; Knowles DM
    Am J Pathol; 1990 Jan; 136(1):29-37. PubMed ID: 2105060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of HLA-DR antigen expression in phytohemagglutinin-activated T cells in man. Requirement of T cell recognition of self HLA-DR antigen expressed on the surface of monocytes.
    Moriya N; Sanjoh K; Yokoyama S; Hayashi T
    J Immunol; 1987 Nov; 139(10):3281-6. PubMed ID: 3500214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
    Howard DR; Eaves AC; Takei F
    Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique proliferation-associated marker expressed on activated and transformed human cells defined by monoclonal antibody.
    Dubey DP; Staunton DE; Parekh AC; Schwarting GA; Antoniou D; Lazarus H; Yunis EJ
    J Natl Cancer Inst; 1987 Feb; 78(2):203-12. PubMed ID: 3543453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
    Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
    J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunobiology of chronic lymphocytic leukemia.
    Freedman AS
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):405-29. PubMed ID: 2182599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte-associated antigen T cells from patients with acute or chronic atopic dermatitis.
    Antúnez C; Torres MJ; Mayorga C; Cornejo-García JA; Santamaría-Babi LF; Blanca M
    Clin Exp Allergy; 2004 Apr; 34(4):559-66. PubMed ID: 15080808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
    Uchiyama T; Hori T; Tsudo M; Wano Y; Umadome H; Tamori S; Yodoi J; Maeda M; Sawami H; Uchino H
    J Clin Invest; 1985 Aug; 76(2):446-53. PubMed ID: 2993359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland.
    Bisset LR; Lung TL; Kaelin M; Ludwig E; Dubs RW
    Eur J Haematol; 2004 Mar; 72(3):203-12. PubMed ID: 14962239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
    Salazar-Gonzalez JF; Moody DJ; Giorgi JV; Martinez-Maza O; Mitsuyasu RT; Fahey JL
    J Immunol; 1985 Sep; 135(3):1778-85. PubMed ID: 2991373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two mouse monoclonal antibodies detecting two different epitopes of an activated lymphocyte antigen on adult T-cell leukemia cells.
    Ueda R; Nishida K; Koide Y; Tsuge I; Seto M; Yoshida M; Miyoshi I; Ota K; Takahashi T
    Cancer Res; 1985 Mar; 45(3):1314-9. PubMed ID: 2578877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.